Insights

We are pleased to announce that the U.S. Food and Drug Administration (FDA) granted Biomeme’s SARS-CoV-2 Real-Time RT-PCR Test Emergency Use Authorization (EUA) for use in laboratories that meet...

“Ahhhh-CHOO!” Cut to me frantically searching “COVID-19 symptoms” on Google for what must be the millionth time this year. “Could I have COVID-19?” It’s a question we’ve all repeatedly asked...

With the results of the AMR Challenge quickly approaching, we wanted to take a moment to reflect on our amazing team’s development activities over an extremely aggressive timeline leading up to the...

We are proud to announce that Biomeme’s portable test solution to detect SARS-CoV-2 was approved for in vitro diagnostic use by Health Canada on June 30, 2020. Our SARS-CoV-2 Real-Time RT-PCR test...

As the United States rolls into month two of Stay at Home and social distancing orders, ramping up COVID-19 testing is a critical step to track and prevent the spread of the SARS-CoV-2 virus to...

We’re happy to announce that we have entered into a research and sales agreement with American Leprosy Missions! This partnership enables ALM to adapt our mobile molecular point-of-need testing...

Ania Tomaszewicz Brown, Denise McAloose, Paul P. Calle, Angelika Auer, Annika Posautz, Sally Slavinski, Robin Brennan, Chris Walzer, and Tracie A. Seimon developed a quantitative RT-PCR assay for...

Biomeme co-founder, Max Perelman answered your most pressing questions related to SARS-CoV-2 and COVID-19. In addition to answering your questions, Max will teach you how to run Biomeme’s end-to-end...

In the time of the virus, it is as important as ever to remain calm and practice preventative measures. At the time of writing, WHO characterized COVID-19 (Coronavirus Disease 2019) as a pandemic and...